Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1989 Jun;33(6):866–870. doi: 10.1128/aac.33.6.866

Effects of a derivative of serotonin (deoxyfructoserotonin) and other antileprosy drugs on attachment and uptake of Mycobacterium leprae by Schwann cells in vitro.

A Choudhury 1, N F Mistry 1, N H Antia 1
PMCID: PMC284247  PMID: 2669627

Abstract

The association (attachment and/or uptake) of Mycobacterium leprae with cultured Schwann cells was studied at 8 and 72 h in the presence of a new antileprosy compound, deoxyfructoserotonin (DFS), as well as conventional antileprosy drugs such as rifampin (RFP) and 4,4'-diaminodiphenyl sulfone (DDS). DFS significantly inhibited bacterial association with Schwann cells at 8 h. RFP also affected the association of M. leprae but not to the same extent as DFS. A similar inhibition at 8 h was noted when M. leprae but not Schwann cells were pretreated with DFS or RFP for 5 days before infection of cultures, implying that modulation was achieved through some form of drug action on bacteria. DDS had no effect on M. leprae association; however, the combination of DFS and DDS was neither antagonistic nor additive. At 72 h postinfection, when attached but noninternalized bacteria were removed with trypsin-EDTA from Schwann cell cultures containing DFS or RFP, a 50% reduction in the number of bacteria in the drug-treated group was obtained as compared with the numbers in drug-free cultures. This indicated a slow entry of M. leprae into Schwann cells in the presence of these drugs. Collectively, these observations point to differing requirements for late and early association of M. leprae with Schwann cells, besides suggesting a role for DFS and RFP in the prevention and minimization of M. leprae-induced nerve damage in vivo.

Full text

PDF
866

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antia N. H., Ambrose E. J., Upleker M. W., Mahadevan P. R., Mester L. Effect of deoxyfructoserotonin (DFS) on lepromatous leprosy. Lancet. 1988 Mar 19;1(8586):619–622. doi: 10.1016/s0140-6736(88)91417-1. [DOI] [PubMed] [Google Scholar]
  2. Antia N. H., Mistry N. F., Kulkarni V. C. Multiplication of armadillo-derived M. leprae in murine dissociated Schwann cell cultures. Int J Lepr Other Mycobact Dis. 1988 Dec;56(4):632–635. [PubMed] [Google Scholar]
  3. Brockes J. P., Fields K. L., Raff M. C. Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve. Brain Res. 1979 Apr 6;165(1):105–118. doi: 10.1016/0006-8993(79)90048-9. [DOI] [PubMed] [Google Scholar]
  4. Itty B. M., Mukherjee R., Antia N. H. Adherence of Mycobacterium leprae to Schwann cells in vitro. J Med Microbiol. 1986 Nov;22(3):277–282. doi: 10.1099/00222615-22-3-277. [DOI] [PubMed] [Google Scholar]
  5. Job C. K. Mycobacterium leprae in nerve lesions in lepromatous leprosy. An electron microscopic study. Arch Pathol. 1970 Mar;89(3):195–207. [PubMed] [Google Scholar]
  6. Mukherjee R., Antia N. H. Intracellular multiplication of leprosy-derived mycobacteria in Schwann cells of dorsal root ganglion cultures. J Clin Microbiol. 1985 May;21(5):808–814. doi: 10.1128/jcm.21.5.808-814.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Mukherjee R., Mahadevan P. R., Antia N. H. Organized nerve culture. I. A technique to study the effect of M. leprae infection. Int J Lepr Other Mycobact Dis. 1980 Jun;48(2):183–188. [PubMed] [Google Scholar]
  8. Saint-André P., Baquillon G., Mester de Parajd L., Mester de Parajd M. Bilan de neuf mois de traitement par la désoxyfructo-sérotonine des lépreux lépromateux. Acta Leprol. 1982 Jan-Jun;(86-87):189–197. [PubMed] [Google Scholar]
  9. Samuel N. M., Mirsky R., Grange J. M., Jessen K. R. Expression of major histocompatibility complex class I and class II antigens in human Schwann cell cultures and effects of infection with Mycobacterium leprae. Clin Exp Immunol. 1987 Jun;68(3):500–509. [PMC free article] [PubMed] [Google Scholar]
  10. Shetty V. P., Mistry N. F., Antia N. H. Serum demyelinating factors and adjuvant-like activity of Mycobacterium leprae: possible causes of early nerve damage in leprosy. Lepr Rev. 1985 Sep;56(3):221–227. doi: 10.5935/0305-7518.19850024. [DOI] [PubMed] [Google Scholar]
  11. Shetty V. P., Vidyasagar P. B., Antia N. H. Study of evolution of nerve damage in leprosy. Part III--Sciatic nerve lesions in mice inoculated with M. leprae with nerve conduction velocity correlates. Lepr India. 1980 Jan;52(1):26–47. [PubMed] [Google Scholar]
  12. Shozushima M. Blocking effect of serotonin on inhibitory dopamine receptor activity of Aplysia ganglion cells. Jpn J Physiol. 1984;34(2):225–243. doi: 10.2170/jjphysiol.34.225. [DOI] [PubMed] [Google Scholar]
  13. Stoner G. L. Importance of the neural predilection of Mycobacterium leprae in leprosy. Lancet. 1979 Nov 10;2(8150):994–996. doi: 10.1016/s0140-6736(79)92564-9. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES